We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.43 | 7.39 | 7.42 | 2,002 | 14:10:14 |
From Apr 2021 to Apr 2024
By Cristina Roca
Bayer AG said Monday that the U.S. Supreme Court has requested the views of the Solicitor General on behalf of the U.S. in a case involving its Roundup herbicide.
The German pharmaceutical and chemical company, which for years has fought a slew of cases over the weedkiller, said it is encouraged by the Supreme Court's move, which follows a petition by Bayer to review the verdict in Monsanto Co. v. Hardeman.
"Now that the Supreme Court has requested input from the Solicitor General in this case, we will not entertain any further settlement discussions with plaintiff lawyers that are representing a substantial number of Roundup claims," the company said.
Bayer maintains that Roundup, which it acquired when it bought agrochemical company Monsanto for $63 billion, doesn't cause cancer.
Write to Cristina Roca at cristina.roca@wsj.com
(END) Dow Jones Newswires
December 13, 2021 10:24 ET (15:24 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
